Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments
Pandemic of coronavirus disease (COVID-19) is still pressing the healthcare systems worldwide. Thus far, the lack of available COVID-19-targeted treatments has led scientists to look through drug repositioning practices and exploitation of available scientific evidence for potential efficient drugs...
Guardado en:
Autores principales: | Marios Spanakis, Athina Patelarou, Evridiki Patelarou, Nikolaos Tzanakis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8e11f03c1724e42be50bdc78ade76c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COVID-19 Vaccine Hesitancy in Healthcare Personnel: A University Hospital Experience
por: Beril Kara Esen, et al.
Publicado: (2021) -
Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models
por: Stevenson JM, et al.
Publicado: (2014) -
The war on COVID-19 and vaccination mandates: Ethical code of conduct
por: Norma Visagie
Publicado: (2021) -
Mechanisms and the clinical relevance of complex drug–drug interactions
por: Roberts AG, et al.
Publicado: (2018) -
Workforce
Publicado: (1997)